CoronaryAtlas logo
CoronaryAtlas
proline
Pathway / Fibrous-cap degradation & rupture

proline

metabolite

Proline metabolism, a marker of collagen turnover, may discriminate plaque erosion from rupture mechanisms in Type 1 MI pathogenesis.

Pathway placement
Cascade stepFibrous-cap degradation & rupture
Confidencelow
RationaleMetabolomic marker associated with plaque erosion vs rupture discrimination; downstream collagen remodeling in fibrous cap.
Also acts inSystemic / off-pathway
Druggability
Not assessed (no mapped human gene target).

Type I vs Type II discrimination

ScoresType-II-associated
R — rupture / Type-I
C — confounder / Type-II
58
A — assay feasibility
42
E — evidence strength
22
T1DI (composite)
3
Specificity differential (R−C)-43.3
Confounder panel (Type-II drivers)
1sepsis / systemic inflammationmag 2
2anemia / acute blood lossn/a
3hypovolemia / dehydrationmag 2
4tachyarrhythmiamag 2
5hypoxemia / respiratory failuren/a
6hypertensive emergencyn/a
7high-demand / peri-operative stressmag 1
Coverage: 4/7 confounders with evidence
Tier: deep-scored (abstract-extracted) · 6 supporting references. See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum, plasma or urine
Collection tube
Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container
Method / principle
LC-MS/MS (targeted metabolomics) or enzymatic colorimetric where available
Reagent / substrate
Stable-isotope-labeled internal standard (MS); or enzyme-coupled Trinder reagent
Platform
LC-MS/MS; some automated chemistry
Turnaround · availability
Send-out / research · Specialized / research

Literature evidence(3)